School Districts Unite Against Insulin Price Fixing Scheme

During a recent board meeting, a significant recommendation was made regarding a potential class action lawsuit against insulin manufacturers, specifically targeting alleged price-fixing practices. The proposal, presented by a board member, centers on a lawsuit currently filed in the United States District Court for New Jersey, which has emerged from Senate investigations into companies like Eli Lilly. These investigations suggest that insulin prices have been artificially inflated, adversely affecting self-funded health care plans.

The board member emphasized that the lawsuit would not incur any costs for the district, as it operates on a contingency fee basis. The aim is to seek equitable and monetary relief for those affected by high insulin prices, ultimately striving to reduce health care costs for district members. The proposal has garnered support from multiple school districts, including Pittsburgh Public Schools and Butler, indicating a collaborative effort to address this pressing issue.

Additionally, the board discussed updates from various representatives, including the Northern Westmoreland Career and Technology Center, which is set to hold a meeting, and the Westmoreland County Intermediate Unit, which recently launched its first podcast and is considering subleasing ClearView. Feedback from a virtual session involving multiple stakeholders has led to a temporary hold on that consideration.

The board is expected to deliberate further on the insulin pricing lawsuit in their upcoming meeting, with hopes of taking decisive action to combat the rising costs of essential medications for individuals with diabetes.